Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Mesothelioma × bosutinib × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10 Leukemia, Myeloid, Chronic-Phase 4 Philadelphia Chromosome 3 Leukemia 3 Breast Neoplasms 3 Bronchiolitis Obliterans Syndrome 2 Translocation, Genetic 1 Pathologic Processes 1 Neoplasms by Histologic Type 1 Neoplasms 1 Neoplasm Metastasis 1 Leukemia, Myeloid 1 Hematologic Diseases 1 Glioblastoma 1 Bone Marrow Diseases 1 Blast Crisis 1 Advanced Breast Cancer (Parts 1 and 2) 1

Interventions

Pemetrexed 11 Cisplatin 10 pembrolizumab 7 Carboplatin 6 Ipilimumab 5 Nivolumab 4 durvalumab 3 LMB-100 3 Gemcitabine 3 tremelimumab 2 tazemetostat 2 anetumab ravtansine 2 Vinorelbine 2 Plicamycin 2 Dexamethasone 2 Cyclophosphamide 2 Bevacizumab 2 vandetanib 1 tocilizumab 1 ribociclib 1 rebastinib 1 pevonedistat 1 olaparib 1 niraparib 1 nintedanib 1 fludarabine phosphate 1 fludarabine 1 epacadostat 1 enzalutamide 1 defactinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡